Literature DB >> 22058154

How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.

Mordecai P Blaustein1, Frans H H Leenen, Ling Chen, Vera A Golovina, John M Hamlyn, Thomas L Pallone, James W Van Huysse, Jin Zhang, W Gil Wier.   

Abstract

Excess dietary salt is a major cause of hypertension. Nevertheless, the specific mechanisms by which salt increases arterial constriction and peripheral vascular resistance, and thereby raises blood pressure (BP), are poorly understood. Here we summarize recent evidence that defines specific molecular links between Na(+) and the elevated vascular resistance that directly produces high BP. In this new paradigm, high dietary salt raises cerebrospinal fluid [Na(+)]. This leads, via the Na(+)-sensing circumventricular organs of the brain, to increased sympathetic nerve activity (SNA), a major trigger of vasoconstriction. Plasma levels of endogenous ouabain (EO), the Na(+) pump ligand, also become elevated. Remarkably, high cerebrospinal fluid [Na(+)]-evoked, locally secreted (hypothalamic) EO participates in a pathway that mediates the sustained increase in SNA. This hypothalamic signaling chain includes aldosterone, epithelial Na(+) channels, EO, ouabain-sensitive α(2) Na(+) pumps, and angiotensin II (ANG II). The EO increases (e.g.) hypothalamic ANG-II type-1 receptor and NADPH oxidase and decreases neuronal nitric oxide synthase protein expression. The aldosterone-epithelial Na(+) channel-EO-α(2) Na(+) pump-ANG-II pathway modulates the activity of brain cardiovascular control centers that regulate the BP set point and induce sustained changes in SNA. In the periphery, the EO secreted by the adrenal cortex directly enhances vasoconstriction via an EO-α(2) Na(+) pump-Na(+)/Ca(2+) exchanger-Ca(2+) signaling pathway. Circulating EO also activates an EO-α(2) Na(+) pump-Src kinase signaling cascade. This increases the expression of the Na(+)/Ca(2+) exchanger-transient receptor potential cation channel Ca(2+) signaling pathway in arterial smooth muscle but decreases the expression of endothelial vasodilator mechanisms. Additionally, EO is a growth factor and may directly participate in the arterial structural remodeling and lumen narrowing that is frequently observed in established hypertension. These several central and peripheral mechanisms are coordinated, in part by EO, to effect and maintain the salt-induced elevation of BP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22058154      PMCID: PMC3311458          DOI: 10.1152/ajpheart.00899.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  288 in total

Review 1.  Pleiotropic effects of cardioactive glycosides.

Authors:  C Riganti; I Campia; J Kopecka; E Gazzano; S Doublier; E Aldieri; A Bosia; D Ghigo
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Role of myosin light chain kinase in regulation of basal blood pressure and maintenance of salt-induced hypertension.

Authors:  Wei-Qi He; Yan-Ning Qiao; Cheng-Hai Zhang; Ya-Jing Peng; Chen Chen; Pei Wang; Yun-Qian Gao; Caiping Chen; Xin Chen; Tao Tao; Xiao-Hong Su; Chao-Jun Li; Kristine E Kamm; James T Stull; Min-Sheng Zhu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-13       Impact factor: 4.733

3.  Mild DOCA-salt hypertension: sympathetic system and role of renal nerves.

Authors:  Sachin S Kandlikar; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-25       Impact factor: 4.733

4.  Regulation of hypothalamic renin-angiotensin system and oxidative stress by aldosterone.

Authors:  Bing S Huang; Hong Zheng; Junhui Tan; Kaushik P Patel; Frans H H Leenen
Journal:  Exp Physiol       Date:  2011-08-08       Impact factor: 2.969

Review 5.  Reactive oxygen species and vascular biology: implications in human hypertension.

Authors:  Rhian M Touyz; Ana M Briones
Journal:  Hypertens Res       Date:  2010-10-28       Impact factor: 3.872

6.  Hypertension from chronic central sodium chloride in mice is mediated by the ouabain-binding site on the Na,K-ATPase α₂-isoform.

Authors:  James W Van Huysse; Iva Dostanic; Jerry B Lingrel; Xiaohong Hou; Hengwei Wu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

7.  Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.

Authors:  Baojian Xue; Terry G Beltz; Yang Yu; Fang Guo; Celso E Gomez-Sanchez; Meredith Hay; Alan Kim Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-26       Impact factor: 4.733

Review 8.  Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.

Authors:  John W Osborn; Gregory D Fink; Marcos T Kuroki
Journal:  Curr Hypertens Rep       Date:  2011-06       Impact factor: 5.369

Review 9.  Transient receptor potential channel activation and endothelium-dependent dilation in the systemic circulation.

Authors:  David X Zhang; David D Gutterman
Journal:  J Cardiovasc Pharmacol       Date:  2011-02       Impact factor: 3.105

10.  Comparative properties of caveolar and noncaveolar preparations of kidney Na+/K+-ATPase.

Authors:  Lijun Liu; Alexander V Ivanov; Marjorie E Gable; Florent Jolivel; Gene A Morrill; Amir Askari
Journal:  Biochemistry       Date:  2011-09-16       Impact factor: 3.162

View more
  90 in total

Review 1.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

Review 2.  Sodium-calcium exchangers (NCX): molecular hallmarks underlying the tissue-specific and systemic functions.

Authors:  Daniel Khananshvili
Journal:  Pflugers Arch       Date:  2013-11-27       Impact factor: 3.657

Review 3.  Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.

Authors:  Mordecai P Blaustein; Ling Chen; John M Hamlyn; Frans H H Leenen; Jerry B Lingrel; W Gil Wier; Jin Zhang
Journal:  J Physiol       Date:  2016-07-31       Impact factor: 5.182

Review 4.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 5.  Livin' with NCX and lovin' it: a 45 year romance.

Authors:  Mordecai P Blaustein
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

6.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

7.  Neuronal (pro)renin receptor regulates deoxycorticosterone-induced sodium intake.

Authors:  Fatima Trebak; Wencheng Li; Yumei Feng
Journal:  Physiol Genomics       Date:  2018-08-24       Impact factor: 3.107

8.  Nanomolar ouabain increases NCX1 expression and enhances Ca2+ signaling in human arterial myocytes: a mechanism that links salt to increased vascular resistance?

Authors:  Cristina I Linde; Laura K Antos; Vera A Golovina; Mordecai P Blaustein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-07-27       Impact factor: 4.733

9.  Effect of global and regional sympathetic blockade on arterial pressure during water deprivation in conscious rats.

Authors:  Britta J Veitenheimer; William C Engeland; Pilar A Guzman; Gregory D Fink; John W Osborn
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

Review 10.  Role of immune cells in salt-sensitive hypertension and renal injury.

Authors:  Brittany Wade; Justine M Abais-Battad; David L Mattson
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.